Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChapel Down Grp Regulatory News (CDGP)

Share Price Information for Chapel Down Grp (CDGP)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £78.90m
CDGP Live PriceLast checked at - London Stock Exchange

Intraday Chapel Down Grp Share Chart

Form 8.3 - CHAPEL DOWN GROUP PLC

23 Sep 2024 14:32

RNS Number : 2869F
FIL Limited
23 September 2024
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CHAPEL DOWN GROUP PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20-September-2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,318,761

1.93%

(2) Cash-settled derivatives:

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

3,318,761

1.93%

 

All interests and all short positions should be disclosed

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

5p ordinary

Sale

5,000

0.52 GBP/Share

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None.

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

23-September-2024

Contact name:

Aaron Watson

Telephone number:

00 353 1 223 1050

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETSEFFDDELSEDU
Date   Source Headline
20th May 20267:00 amRNSPosting of Annual Report and Notice of AGM
29th Apr 20267:00 amRNSResults for the period ended 31 December 2025
21st Apr 20267:00 amRNSNotice of Results and Investor Presentation
29th Jan 20267:00 amRNSUnaudited Trading Statement period ended 31/12/25
3rd Dec 20254:49 pmRNSDirector/PDMR Shareholding
2nd Dec 20255:14 pmRNSDirector/PDMR Shareholding
27th Oct 20253:12 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSHarvest Update
24th Sep 20257:02 amRNSDirectorate Change
24th Sep 20257:00 amRNSUnaudited Results for the period ended 30/06/2025
15th Sep 20257:00 amRNSNotice of Results and Investor Presentation
27th Aug 20257:00 amRNSBoard Appointment
1st Aug 202511:27 amRNSGRANT OF OPTIONS AND DIRECTOR/PDMR DEALING
31st Jul 20257:01 amRNSDirectorate Change
31st Jul 20257:00 amRNSH1 2025 Trading Update
24th Jun 20252:12 pmRNSResult of AGM
30th May 20257:00 amRNSNotice of AGM
8th Apr 20257:00 amRNSCFO formal appointment
3rd Apr 20257:00 amRNSResults for the period ended 31 December 2024
28th Mar 20254:12 pmRNSNotice of Results and Investor Presentation
4th Mar 20257:00 amRNSChief Financial Officer Appointment
24th Feb 202511:00 amRNSPDMR / PCA Dealing
19th Feb 20252:30 pmRNSPDMR / PCA Dealing
3rd Feb 20257:00 amRNSCEO Formal Appointment
23rd Jan 20257:00 amRNSUnaudited Trading Statement ended 31/12/2024
16th Dec 20244:15 pmRNSPDMR / PCA Dealing
16th Dec 20244:15 pmRNSHolding(s) in Company
13th Dec 20247:00 amRNSCEO Appointment, Directorate Change & Outlook
28th Oct 202411:42 amRNSForm 8.5 (EPT/RI)
25th Oct 202412:40 pmRNSUpdate on Strategic Review, Harvest & Trading
25th Oct 202411:53 amRNSForm 8.5 (EPT/RI)
24th Oct 202411:35 amRNSForm 8.5 (EPT/RI)
23rd Oct 202411:56 amRNSForm 8.5 (EPT/RI)
22nd Oct 202410:30 amRNSForm 8.5 (EPT/RI)
21st Oct 202411:55 amRNSForm 8.5 (EPT/RI)
18th Oct 202411:59 amRNSForm 8.5 (EPT/RI)
17th Oct 202410:41 amRNSForm 8.5 (EPT/RI)
16th Oct 20242:55 pmRNSForm 8.3 - CHAPEL DOWN GROUP PLC
16th Oct 202412:03 pmRNSForm 8.5 (EPT/RI)
15th Oct 20242:22 pmRNSForm 8.3 - CHAPEL DOWN GROUP PLC
15th Oct 202411:39 amRNSForm 8.5 (EPT/RI)
14th Oct 202411:47 amRNSForm 8.5 (EPT/RI)
11th Oct 20244:17 pmRNSForm 8.3 - CHAPEL DOWN GROUP PLC
11th Oct 202410:51 amRNSForm 8.5 (EPT/RI)
10th Oct 20246:29 pmRNSForm 8.3 - Chapel Down Group PLC
10th Oct 20243:18 pmRNSForm 8.3 - CHAPEL DOWN GROUP PLC
10th Oct 202411:42 amRNSForm 8.5 (EPT/RI)
9th Oct 20243:04 pmRNSForm 8.3 - CHAPEL DOWN GROUP PLC
9th Oct 202410:40 amRNSForm 8.5 (EPT/RI)
8th Oct 20241:29 pmRNSForm 8.3 - CHAPEL DOWN GROUP PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.